
Nymox Pharmaceutical Corporation NYMX
Geschäftsbericht 2024
hinzugefügt 25.04.2026
Nymox Pharmaceutical Corporation DPO 2011-2026 | NYMX
DPO Jährlich Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 2.41 K | 4.19 K | 3.12 K | 1.04 K | 1.27 K | 807 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.19 K | 807 | 2.14 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
5.06 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 16.81 | -2.83 % | $ 786 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.61 | 1.26 % | $ 428 M | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 2.77 | -8.75 % | $ 259 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.6 | -2.15 % | $ 187 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 0.72 | -2.32 % | $ 32.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.13 | 0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
74.3 | $ 30.12 | -1.94 % | $ 810 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
148 | $ 50.55 | -1.08 % | $ 13.7 B | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 21.54 | -0.16 % | $ 2.74 B | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.39 | 3.91 % | $ 66.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Fennec Pharmaceuticals
FENC
|
894 | $ 10.11 | 9.36 % | $ 289 M |